Related Experiment Video
Updated: Jul 5, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation
1Program in Apoptosis and Cell Death Research, Burnham Institute for Medical Research, La Jolla, California 92037, USA.
Abstract:
The apoptosis-modulating protein Daxx functions as a transcriptional repressor that binds to and suppresses the activity of nuclear factor-kappaB member RelB, among other transcription factors. The mechanism by which Daxx represses RelB target genes remains elusive. In this report, we demonstrate that Daxx controls epigenetic silencing of RelB target genes by DNA methylation. Daxx potently represses the RelB target genes dapk1, dapk3, c-flip, and birc3 (ciap2) at both the mRNA and protein levels. Recruitment of Daxx to target gene promoters, and its ability to repress them, is RelB-dependent, as shown by experiments using relB(-/-) cells. Importantly, methylation of target promoters is decreased in daxx(-/-) cells compared with daxx(+/+) cells, and stable transfection of daxx(-/-) cells with Daxx restores DNA methylation. Furthermore, Daxx recruits DNA methyl transferase 1 (Dnmt1) to target promoters, resulting in synergistic repression. The observation that Daxx functions to target DNA methyltransferases onto RelB target sites in the genome provides a rare example of a gene-specific mechanism for epigenetic silencing. Given the documented role of several of the RelB-regulated genes in diseases, particularly cancer, the findings have implications for developing therapeutic strategies based on epigenetic-modifying drugs.
Insights
The apoptosis-modulating protein Daxx epigenetically silences RelB target genes via DNA methylation. Daxx recruits DNA methyltransferase 1 to promoters, offering therapeutic strategies for diseases like cancer.
Area of Science:
- Epigenetics
- Molecular Biology
- Gene Regulation
Background:
- Daxx is a transcriptional repressor that inhibits nuclear factor-kappaB member RelB.
- The mechanism of Daxx-mediated repression of RelB target genes was previously unknown.
Purpose of the Study:
- To elucidate the mechanism by which Daxx represses RelB target genes.
- To investigate the role of Daxx in epigenetic silencing through DNA methylation.
Main Methods:
- Utilized relB(-/-) cells to assess RelB-dependent Daxx recruitment and repression.
- Analyzed DNA methylation levels in daxx(-/-) and daxx(+/+) cells.
- Investigated the recruitment of DNA methyltransferase 1 (Dnmt1) by Daxx to target promoters.
Main Results:
- Daxx represses RelB target genes (dapk1, dapk3, c-flip, birc3) at mRNA and protein levels.
- Daxx-mediated repression is RelB-dependent.
- Daxx deficiency reduces target promoter methylation; Daxx reintroduction restores it.
- Daxx recruits Dnmt1 to target promoters, leading to synergistic repression.
Conclusions:
- Daxx mediates epigenetic silencing of RelB target genes through DNA methylation.
- This study reveals a gene-specific mechanism for epigenetic silencing.
- Findings have implications for epigenetic-modifying cancer therapies.
More Related Videos
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
08:54In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression
Published on: March 29, 2019
Related Concept Videos
Co-activators and Co-repressors
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
RNA Polymerase II Accessory Proteins
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators